Related Experiment Video
Updated: Jan 20, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
Published on: July 6, 2017
Genetics of gastric cancer: what do we know about the genetic risks?
Thomas Paul Slavin1,2,3, Jeffrey N Weitzel1,2,3, Susan L Neuhausen2,3
1Division of Clinical Cancer Genomics, Department of Medical Oncology and Therapeutics Research, City of Hope, Duarte, CA, USA.
Abstract:
An appreciable number of patients with gastric cancer have an underlying hereditary cancer susceptibility syndrome as the cause of their gastric cancer, particularly those with early onset gastric cancer or a family history of gastric or other cancers. Pathogenic germline variants in specific genes account for the known gastric cancer predisposition syndromes. Germline genetic testing can identify individuals and their family members who carry inherited pathogenic gene variants, and thus have increased risk of developing gastric or other cancers. Ideally, germline pathogenic variants can be identified in family members before the onset of disease, when early detection or prevention strategies can be implemented most effectively to decrease gastric cancer- related morbidity and mortality. This article reviews some of the currently known gastric cancer predisposition syndromes and their associated cancer risks. We also discuss current research and advances in the field of genetic gastric cancer susceptibility.
Related Concept Videos
Genetics of Speciation
What is Population Genetics?
An Overview of Genetics and Disease
What is Genetic Engineering?
An Overview of Genetic Engineering
06:01A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer